Skip to main content

Table 3 Mean increases in creatinine and cystatin C on days 2, 4 and 10 compared with day 0, in the two groups

From: N-acetylcysteine does not prevent contrast nephropathy in patients with renal impairment undergoing emergency CT: a randomized study

 

Placebo

NAC

P-value

(n = 58)

(n = 52)

Day 2

   

  Creatinine

−3.60 ± 35.84

−3.66 ± 38.69

0.96

  Cystatin C

−0.02 ±0.43

0.06 ± 0.44

0.30

Day 4

   

  Creatinine

−8.25 ± 65.62

−8.37 ± 36.52

0.37

  Cystatin C

−0.04 ± 0.57

−0.04 ± 0.41

0.30

Day 10

   

  Creatinine

−14.94 ± 75.53

−16.53 ± 25.23

0.25

  Cystatin C

−0.12 ± 0.54

−0.07 ± 0.34

0.27

Peak increase

   

  Creatinine

9.38 ± 70.91

4.63 ± 38.14

0.54

  Cystatin C

0.06 ± 0.56

0.17 ± 0.43

0.07